Insider Transactions in Q1 2020 at Cvs Health Corp (CVS)
Insider Transaction List (Q1 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 30
2020
|
James David Clark SVP, Cont & Chief Acct Officer |
SELL
Open market or private sale
|
Direct |
3,030
-23.69%
|
$181,800
$60.0 P/Share
|
|
Mar 30
2020
|
James David Clark SVP, Cont & Chief Acct Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,030
+19.15%
|
$163,620
$54.53 P/Share
|
|
Feb 28
2020
|
Lisa Bisaccia Former EVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,202
-12.52%
|
$365,918
$59.18 P/Share
|
|
Feb 28
2020
|
Lisa Bisaccia Former EVP & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,587
+27.29%
|
$1,096,633
$59.18 P/Share
|
|
Feb 28
2020
|
Eva C Boratto EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
13,330
-8.22%
|
$786,470
$59.18 P/Share
|
|
Feb 28
2020
|
Eva C Boratto EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
33,795
+29.28%
|
$1,993,905
$59.18 P/Share
|
|
Feb 28
2020
|
Troyen A Brennan EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,255
-8.44%
|
$546,045
$59.18 P/Share
|
|
Feb 28
2020
|
Troyen A Brennan EVP and Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,346
+18.77%
|
$1,495,414
$59.18 P/Share
|
|
Feb 28
2020
|
James David Clark SVP, Cont & Chief Acct Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,912
+11.49%
|
$112,808
$59.18 P/Share
|
|
Feb 28
2020
|
James David Clark SVP, Cont & Chief Acct Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
347
-3.43%
|
$20,473
$59.18 P/Share
|
|
Feb 28
2020
|
Joshua Matthew Flum EVP, ENT STRATEGY & DIGITAL |
BUY
Grant, award, or other acquisition
|
Direct |
1
+0.01%
|
$59
$59.18 P/Share
|
|
Feb 28
2020
|
Joshua Matthew Flum EVP, ENT STRATEGY & DIGITAL |
SELL
Payment of exercise price or tax liability
|
Direct |
1,524
-3.2%
|
$89,916
$59.18 P/Share
|
|
Feb 28
2020
|
Joshua Matthew Flum EVP, ENT STRATEGY & DIGITAL |
BUY
Grant, award, or other acquisition
|
Direct |
3,379
+11.97%
|
$199,361
$59.18 P/Share
|
|
Feb 28
2020
|
Alan Lotvin EVP&President-PharmacyServices |
BUY
Grant, award, or other acquisition
|
Direct |
11,828
+29.74%
|
$697,852
$59.18 P/Share
|
|
Feb 28
2020
|
Alan Lotvin EVP&President-PharmacyServices |
SELL
Payment of exercise price or tax liability
|
Direct |
160
-1.89%
|
$9,440
$59.18 P/Share
|
|
Feb 28
2020
|
Larry J Merlo Director |
SELL
Payment of exercise price or tax liability
|
Direct |
51,714
-9.38%
|
$3,051,126
$59.18 P/Share
|
|
Feb 28
2020
|
Larry J Merlo Director |
BUY
Grant, award, or other acquisition
|
Direct |
114,058
+17.15%
|
$6,729,422
$59.18 P/Share
|
|
Feb 28
2020
|
Thomas M Moriarty EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
13,457
-17.95%
|
$793,963
$59.18 P/Share
|
|
Feb 28
2020
|
Thomas M Moriarty EVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
31,683
+29.71%
|
$1,869,297
$59.18 P/Share
|
|
Feb 28
2020
|
Jonathan C Roberts EVP & Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
63,366
+17.66%
|
$3,738,594
$59.18 P/Share
|
|
Feb 28
2020
|
Derica W Rice EVP & President, CVS Caremark |
SELL
Payment of exercise price or tax liability
|
Direct |
8,079
-23.15%
|
$476,661
$59.18 P/Share
|
|
Feb 28
2020
|
Derica W Rice EVP & President, CVS Caremark |
BUY
Grant, award, or other acquisition
|
Direct |
21,943
+38.6%
|
$1,294,637
$59.18 P/Share
|
|
Feb 27
2020
|
Joshua Matthew Flum EVP, ENT STRATEGY & DIGITAL |
SELL
Payment of exercise price or tax liability
|
Direct |
844
-3.98%
|
$49,796
$59.33 P/Share
|
|
Feb 18
2020
|
Karen S Lynch President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
14,215
-15.26%
|
-
|
|
Jan 15
2020
|
Larry J Merlo Director |
SELL
Open market or private sale
|
Direct |
266,476
-37.88%
|
$19,719,224
$74.79 P/Share
|
|
Jan 15
2020
|
Larry J Merlo Director |
BUY
Exercise of conversion of derivative security
|
Direct |
314,713
+30.91%
|
$16,994,502
$54.53 P/Share
|
|
Jan 08
2020
|
Jonathan C Roberts EVP & Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
57,563
-56.1%
|
$4,144,536
$72.63 P/Share
|
|
Jan 08
2020
|
Jonathan C Roberts EVP & Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
68,844
+40.15%
|
$3,717,576
$54.53 P/Share
|